ArticleArteriosclerosis, thrombosis, and vascular biology2026

Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease.

Xiaoxi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.